101 related articles for article (PubMed ID: 30955261)
1. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261
[No Abstract] [Full Text] [Related]
2. ROS1 fusions in Chinese patients with non-small-cell lung cancer.
Cai W; Li X; Su C; Fan L; Zheng L; Fei K; Zhou C; Manegold C; Schmid-Bindert G
Ann Oncol; 2013 Jul; 24(7):1822-1827. PubMed ID: 23514723
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal origin.
Graziano P; Parente P; Centra F; Milione M; Centonze G; Volante M; Cavazza A; Urbano D; Di Maggio G; Balsamo T; Di Micco C; Rossi G; Rossi A; Muscarella LA
Virchows Arch; 2024 Jan; 484(1):37-46. PubMed ID: 37773451
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
Sakamoto T; Matsubara T; Takahama T; Yokoyama T; Nakamura A; Tokito T; Okamoto T; Akamatsu H; Oki M; Sato Y; Tobino K; Ikeda S; Mori M; Mimura C; Maeno K; Miura S; Harada T; Nishimura K; Hiraoka M; Kenmotsu H; Fujimoto J; Shimokawa M; Yamamoto N; Nakagawa K
JAMA Netw Open; 2023 Dec; 6(12):e2347700. PubMed ID: 38100106
[TBL] [Abstract][Full Text] [Related]
6. Non-Small Cell Lung Cancer: Targetable Variants in Concurrent Tissue and Liquid Biopsy Testing in a North Indian Cohort.
Paturu R; Lingaiah R; Kumari N; Singh S; Krishnani N; Srivastava S; Siddiqui SH; Nath A
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3467-3475. PubMed ID: 37898852
[TBL] [Abstract][Full Text] [Related]
7. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
9. A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis.
Firoz WA; Sen F; Kiuru M; Huang V; Riess JW
Clin Lung Cancer; 2024 Jun; 25(4):380-383. PubMed ID: 38429142
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.
Fukui T; Tsuta K; Furuta K; Watanabe S; Asamura H; Ohe Y; Maeshima AM; Shibata T; Masuda N; Matsuno Y
Cancer Sci; 2007 Nov; 98(11):1714-9. PubMed ID: 17784875
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].
Han J; Gao XZ; Xu Y; Liu EJ; Du Q; Chen K; Li SL
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):136-142. PubMed ID: 38281780
[No Abstract] [Full Text] [Related]
12. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
Dong J; Zhang RY; Sun N; Smalley M; Wu Z; Zhou A; Chou SJ; Jan YJ; Yang P; Bao L; Qi D; Tang X; Tseng P; Hua Y; Xu D; Kao R; Meng M; Zheng X; Liu Y; Vagner T; Chai X; Zhou D; Li M; Chiou SH; Zheng G; Di Vizio D; Agopian VG; Posadas E; Jonas SJ; Ju SP; Weiss PS; Zhao M; Tseng HR; Zhu Y
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13973-13983. PubMed ID: 30892008
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
Bernardi FDC; Bernardi MDC; Takagaki T; Siqueira SAC; Dolhnikoff M
Clinics (Sao Paulo); 2018 Oct; 73():e361. PubMed ID: 30379223
[TBL] [Abstract][Full Text] [Related]
14. miR-31 Displays Subtype Specificity in Lung Cancer.
Davenport ML; Echols JB; Silva AD; Anderson JC; Owens P; Yates C; Wei Q; Harada S; Hurst DR; Edmonds MD
Cancer Res; 2021 Apr; 81(8):1942-1953. PubMed ID: 33558335
[TBL] [Abstract][Full Text] [Related]
15. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities.
Simbolo M; Centonze G; Ali G; Garzone G; Taormina S; Sabella G; Ciaparrone C; Mafficini A; Grillo F; Mangogna A; Volante M; Mastracci L; Fontanini G; Pilotto S; Bria E; Infante M; Capella C; Rolli L; Pastorino U; Milella M; Milione M; Scarpa A
ESMO Open; 2022 Feb; 7(1):100308. PubMed ID: 34952268
[TBL] [Abstract][Full Text] [Related]
16. Integrated classification of lung tumors and cell lines by expression profiling.
Virtanen C; Ishikawa Y; Honjoh D; Kimura M; Shimane M; Miyoshi T; Nomura H; Jones MH
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12357-62. PubMed ID: 12218176
[TBL] [Abstract][Full Text] [Related]
17. The morphological and molecular diagnosis of lung cancer.
Petersen I
Dtsch Arztebl Int; 2011 Aug; 108(31-32):525-31. PubMed ID: 21886665
[TBL] [Abstract][Full Text] [Related]
18. Predictive advantage of a cell type classification for pulmonary adenocarcinoma coupled with data for p53, K-ras and EGFR alterations.
Okada A; Shimmyo T; Hashimoto T; Kobayashi Y; Miyagi Y; Ishikawa Y; Nakagawa K; Hayashi J; Tsuchiya E
Cancer Sci; 2010 Jul; 101(7):1745-53. PubMed ID: 20491778
[TBL] [Abstract][Full Text] [Related]
19. Advances in combined neuroendocrine carcinoma of lung cancer.
Han Z; Yang F; Wang F; Zheng H; Chen X; Meng H; Li F
Pathol Oncol Res; 2024; 30():1611693. PubMed ID: 38807858
[TBL] [Abstract][Full Text] [Related]
20. CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer.
Lian W; Ouyang Y
Oncol Lett; 2017 May; 13(5):3415-3422. PubMed ID: 28521447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
